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Background: To overcome the limitations of animal-based experiments, 3D culture models mimicking the tumor
microenvironment in vivo are gaining attention. Herein, we investigated an alginate-based 3D scaffold for screening
of 5-fluorouracil (5-FU) or/and curcumin on malignancy of colorectal cancer cells (CRC).
Methods: The potentiation effects of curcumin on 5-FU against proliferation and metastasis of HCT116 cell and its
corresponding isogenic 5-FU-chemoresistant cells (HCT116R) were examined in a 3D-alginate tumor model.
Results: CRC cells encapsulated in alginate were able to proliferate in 3D-colonospheres in a vivo-like phenotype
and invaded from alginate. During cultivation of cells in alginate, we could isolate 3 stages of cells, (1) alginate
proliferating (2) invasive and (3) adherent cells. Tumor-promoting factors (CXCR4, MMP-9, NF-κB) were significantly
increased in the proliferating and invasive compared to the adherent cells, however HCT116R cells overexpressed
factors in comparison to the parental HCT116, suggesting an increase in malignancy behavior. In alginate, curcumin
potentiated 5-FU-induced decreased capacity for proliferation, invasion and increased more sensitivity to 5-FU of
HCT116R compared to the HCT116 cells. IC50 for HCT116 to 5-FU was 8nM, but co-treatment with 5 μM curcumin
significantly reduced 5-FU concentrations in HCT116 and HCT116R cells (0.8nM, 0.1nM, respectively) and these
effects were accompanied by down-regulation of NF-κB activation and NF-κB-regulated gene products.
Conclusions: Our results demonstrate that the alginate provides an excellent tumor microenvironment and
indicate that curcumin potentiates and chemosensitizes HCT116R cells to 5-FU-based chemotherapy that may be
useful for the treatment of CRC and to overcome drug resistance.
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Conventional in vitro monolayer cell cultures that are
frequently used for cell biology studies or for drug devel-
opment are not representative of the cellular environ-
ment observed in vivo. In fact, the cells in monolayer
cultures, by virtue of lack of tissue-specific architecture,
demonstrate a dramatically reduced malignant pheno-
type compared to the tumor cells in in vivo settings
[1,2]. For these reasons, the results obtained from mono-
layer in vitro cultures often cannot be translated to
in vivo conditions. This is, in part due to the lack of an* Correspondence: mehdi.shakibaei@med.uni-muenchen.de
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that can create and mimic a three dimensional (3D)
in vivo metastasis situation. These limitations highlight
the need for identifying and developing better in vitro
3D culture models of human cancer that will create a
microenvironment that mimics the tumor microenviron-
ment in vivo to optimize number of experiments through
in vitro pre-testing, allowing screening of anti-metastasis
drugs and mechanistic investigations under much more
controllable environment [3]. Thus, the availability of ad-
equate in vitro 3D culture models with better physio-
logical relevance may have big potential as a research tool
in cell biology and tumor biology.
3D alginate culture, comprising of naturally occurring
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eering and tumor research [4-6]. Indeed, several reports
have suggested that cultivation of tumor cells in alginate
induces cell proliferation, survival, production of extra-
cellular matrix compounds, tumor invasion and malig-
nancy [7-10]. Moreover, the alginate scaffolds with
spheroids can be dissolved for further investigation by
adding sodium citrate solution without cell damage [11].
Therefore, alginate 3D scaffolds may facilitate our un-
derstanding of tumor cell behavior, malignancy, ultim-
ately improve the quality of in vitro drug screening, pre-
testing clinical treatments and minimizing animal-based
experiments.
The transcription factor, nuclear factor-kappaB (NF-κB),
is composed of proteins with a molecular mass of 50 kDa
(p50) and 65 kDa (p65) and is contained within the cyto-
plasm by its inhibitory subunit, IκBα. Through phosphor-
ylation and activation, IκBα dissociates from the complex,
and the NF-κB subunits freely translocate to the cell nu-
cleus, where it regulates gene expression [12]. Several lines
of evidence have shown that NF-κB plays an important
role in cell survival, proliferation, invasion, angiogenesis,
metastasis and chemoresistance in multiple tumor types
including CRC [13,14]. Furthermore, NF-κB is constitu-
tively activated in human CRC cells and is associated with
cell progression [15,16], cell growth by inhibiting apop-
tosis [17], cell migration and invasion [18], cell metastasis
by regulating matrix metalloproteinase-9 [19] and cell
promotion by regulating cyclooxygenase-2 [20], which
collectively may help mediate chemoresistance and radio-
resistance of tumor cells [21]. Therefore, chemopreventive
agents that can suppress NF-κB activation might reduce
chemoresistance and may have therapeutic potential to
prevent tumor development like CRC. Curcumin (diferu-
loylmethane), a biologically active phytochemical compo-
nent from the spice turmeric (curcuma longa), is one such
agent. It has been demonstrated that curcumin is nontoxic
in humans [22] and can block NF-κB activation and
NF-κB associated gene products [23-26]. Moreover,
curcumin has been shown to potentiate the cytotoxic
effects of several chemotherapeutic agents such as pac-
litaxel, docetaxel, 5-FU and gemcitabine in malignant
cells, suppressing the three major stages of carcinogenesis
(i.e., initiation, promotion and progression) in vitro and
in vivo [26-35].
5-FU is widely used as a chemotherapeutic agent for
the treatment of many types of cancers and has a chem-
ical structure similar to that of uracil and thymine [36].
5-FU treatment blocks cancer cell proliferation and in-
duces apoptosis by incorporation of its metabolites into
DNA and RNA as a thymidylate synthase inhibitor to
block dTMP synthesis [37]. High metastasis and recur-
rence rate of tumor cells after resection in patients is a
major clinical problem, primarily due to progressiveresistance of tumor cells to chemotherapeutic drugs and
toxicity to surrounding healthy cells [38-40]. Indeed, it
has been suggested that almost 50% of patients with
CRC, may develop recurrent disease [41], indicating that
no effective therapies with chemotherapeutic drugs are
available to prevent metastasis and there is a great need
for improved therapies and novel treatment approaches.
In the present study, we have investigated the suitabil-
ity of a 3D alginate tumor model to study CRC behavior
in vitro (the initial steps of spontaneous carcinogenesis
and metastasis) and investigated in this optimized tumor
microenvironment, whether the combination of curcumin
and 5-FU has synergistic anti-tumor or modulatory effects
on HCT116 and their 5-FU-chemoresistant counterparts.
Methods
Reagents and antibodies
Growth medium (Ham’s F-12/Dulbecco’s modified Eagle’s
medium (50:50) containing 10% fetal bovine serum (FBS),
25 mg/ml ascorbic acid, 50 IU/ml streptomycin, 50 IU/ml
penicillin, essential amino acids and L-glutamine) and
Trypsin/EDTA (EC 3.4.21.4) were obtained from Bio-
chrom (Berlin, Germany). Epon was obtained from Plano
(Marburg, Germany). 5-FU and alginate were purchased
from Sigma (Munich, Germany). Curcumin (BCM-95)
was a generous gift from Dolcas Biotech (Landing, NJ,
USA). Curcumin was prepared by dissolving it in
dimethylsulfoxide (DMSO) at a stock concentration of
5000 mM and stored at −20°C. Serial dilutions were
prepared in culture medium. A 100 mM stock of 5-FU
was prepared in absolute DMSO and stored at −20°C.
The concentration of DMSO was less than 1% of drug
treatment. For treatment, 5-FU was diluted in DMEM and
added to cultures to give the desired final concentration.
Polyclonal antibody against CXCR4 was purchased from
Abcam PLC (Cambridge, UK). Antibodies to β-actin were
from Sigma (Munich, Germany). Anti-MMP-9 was pur-
chased from R&D Systems, Inc., (Heidelberg, Germany).
Anti-phospho-specific p65 (NF-κB) was obtained from
Cell Technology (Beverly, MA, USA). Alkaline phosphat-
ase linked sheep anti-mouse and sheep anti-rabbit second-
ary antibodies for immunoblotting were purchased from
Millipore (Schwalbach, Germany). All antibodies were
used at concentrations and dilutions recommended by the
manufacturer.
Cell lines and cell culture
Human colon cancer cells (HCT116) were obtained from
the European Collection of Cell Cultures (Salisbury, UK).
We also generated 5-FU resistant derivatives of this cell
line, referred to as HCT116R respectively, that was cre-
ated by repetitive treatment of the parental cell lines to in-
creasing concentrations of 5-FU over a 10–12 month
period, as previously described [42]. Both the parental and
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cacy of individual and combined 5-FU and curcumin
treatments. The cells were maintained in tissue culture
flasks in growth medium and in a humidified incubator at
37°C in an atmosphere of 95% air and 5% CO2. The
medium was changed every three days, and cells were pas-
saged using Trypsin/EDTA.
Alginate culture
A detailed description of the cell cultivation in alginate
is given by Shakibaei and de Souza [4]. Briefly, the pellet
of HCT116 and HCT116R cells (1 × 106/ml) was resus-
pended in alginate (2% in 0.15 M NaCl, stirring for 1–2 h)
and slowly added dropwise into a solution containing
100 mM CaCl2 at ambient temperature (AT). The alginate
beads polymerized in the presence of CaCl2 after 10 min.
Subsequently, the CaCl2 solution was removed and the al-
ginate beads washed three times with 0.15 M NaCl solu-
tion and twice with serum-starved medium (3% FBS).
Alginate beads were left untreated, treated with various
concentrations of curcumin (0.1, 1, 5, 10, 20 μM), 5-FU
(0.01, 0.1, 1, 10nM) or the combinational treatment of
curcumin/5-FU (5 μM/0.01nM or 5 μM/0.1nM) in
serum-starved medium, as previously described [26].
The medium was changed every 3 days. The cultures
were grown in an incubator at 37°C with 5% CO2 in air.
Phase contrast of alginate bead cultures
In order to investigate the behavior and vitality of CRC
cells in alginate bead culture, whole alginate beads left
untreated, treated with various concentrations of curcumin
(0.1, 1, 5, 10, 20 μM), 5-FU (0.01, 0.1, 1, 10nM), or the com-
binational treatment of curcumin/5-FU (5 μM/0.01nM or
5 μM/0.1nM) in serum-starved medium were visualized at
days 1, 3, 7, 14, 21, 28 and 35 under a light microscope
(Zeiss, Germany).
Invasion (migration) assay
HCT116 and HCT116R cell lines (1 × 106/ml) were
cultured in alginate beads in petri dishes for 3 weeks as
described in detail above to evaluate cell invasion cap-
acity. After an incubation time of 4–7 days, cells began
to invade from alginate cultures and adhered at the bot-
tom of the culture flask and formed colonies. During
cultivation of cells in the same alginate cultures, we have
isolated 3 stages of cells, (1) in alginate proliferating-, (2)
active invasive- and (3) on the bottom of culture plate
adhered cells, which were all taken for further investiga-
tion. Invasive cells that migrated through the alginate
beads and formed adhered colonies on the bottom of the
petri dish were stained with toluidine blue for 5 minutes
and carefully washed two times with PBS. The number of
migrated and positive stained adhered colonies were
quantified and evaluated manually by counting all coloniesunder a light microscope (Zeiss, Germany) and visualized.
This assay was repeated every 3 to 4 days until day 28 of
culture. The mean number of colonies in triplicate was
calculated and is reported in each bar of the graph. Each
experiment was repeated at least three times.
Western blot analysis
Whole cell extracts for western blot analysis were ob-
tained from alginate beads, from medium (containing
the emigrated, swimming spheroids) and from adhered
colonies. Cells were released from alginate beads, by dis-
solving in 55 mM Sodium citrate solution (1,618 g So-
dium citrate in 100 mL 0,15 M NaCl) for 20–30 min.
Excess alginate was removed by washing twice with ster-
ile Hanks Salt Solution and centrifugation. Medium con-
taining emigrated spheroids was centrifuged and the
supernatant discarded. Lysis buffer was added to the cell
pellet obtained from alginate culture, to the cell pellet
obtained from medium or directly onto adhered colonies
on ice for 30 min. After homogenization and centrifuga-
tion for 30 min at 10.000 rpm, the supernatant was
transferred into a new tube and stored at −80°C. Subse-
quently, total protein content was measured with the
bicinchinonic acid system (Uptima, France) using bovine
serum albumin as standard, proteins were reduced with
2-mercaptoethanol and total protein concentrations
adjusted. Proteins (500 ng per lane total protein) were
separated with SDS-PAGE under reducing conditions on
5-12% polyacrylamidgels. After blotting onto a nitrocel-
lulose membrane using a trans blot apparatus (Bio-Rad,
Munich), membranes were incubated with a primary
antibody overnight at 4°C in blocking buffer (skimmed
milk powder in phosphate buffered saline (PBS)/0.1%
Tween 20), followed by incubation with the alkaline
phosphatase conjugated secondary antibodies for two
hours at AT. Specific antigen-antibody complexes were
detected using nitroblue tetrazolium and 5-bromo-4-
chloro-3-indoylphosphate (p-toluidine salt; Pierce, Rock-
ford, IL) as substrates for alkaline phosphatase. Semi-
quantitative evaluation was performed with densitometry
(Quantity One, Bio-Rad, Munich). Specific β-actin anti-
body was used for the internal control to normalize the
sample amounts.
Electron microscopy
The alginate beads were fixed for 1 h in Karnovsky’s
fixative followed by post-fixation in a 1% OsO4 solution
in phosphate buffer. After rinsing and dehydration in as-
cending alcohol series, the specimens were embedded in
Epon and ultrathin sections prepared with a Reichert-
Jung Ultracut E (Darmstadt, Germany). Sections were
contrasted with 2% uranyl acetate/lead citrate and exam-
ined under a Zeiss transmission electron microscope,
Jena, Germany (TEM 10, Institute of Pharmacology,
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Japan (Department of Anatomy and Cell Biology, Munich,
Germany).
Quantification of apoptotic cell death
To quantify apoptosis and cells with mitochondrial
changes (MC), we used the ultrathin sections of the
samples and examined them with an electron micro-
scope. The number of cells exhibiting typical morpho-
logical features of apoptotic cell death was determined
by scoring 100 cells from 25 different microscopic
fields per culture. The values were initially subjected to
one-way ANOVA and then later compared among
groups using unpaired Student’s t-test, followed by a
post-hoc test to compare the parameters of each
group.
MTT assay from alginate bead culture
To evaluate cell viability of colorectal cancer cells in al-
ginate bead culture, cells were retrieved from alginate
and a MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide) was performed. To release
the cells from the alginate, alginate beads were washed
two times with sterile Hanks Salt Solution and dissolved
in 55 mM sodium citrate solution. Complete dissolving
of the beads was observed after 20–30 min. To remove
excess alginate, cells were centrifuged, washed twice with
sterile Hanks Salt Solution and resuspended in 2 ml
modified cell culture medium (DMEM without phenol
red, without ascorbic acid and only 3% FBS). Subse-
quently, 100 μl of cell suspension was distributed to a
96-well-plate, to each well were immediately added 10 μl
MTT solution (5 mg/ml) and the plate was incubated for
4 h at 37°C. Finally, 100 μl of the MTT solubilisation
solution (10% Triton x-100/acidic isopropanol) was added
per well, and the cells incubated overnight at 37°C. Meta-
bolically active tumor cells were evaluated through meas-
uring the Optical Density at 550 nm (OD550) using
revelation 96-well multiscanner plate ELISA reader
(Bio-Rad Laboratories Inc. Munich, Germany). The
values of IC50 (concentration which inhibited 50% of
cells) was determined at each of the time intervals, by
plotting data on cell viability vs silibinin concentration.
The results obtained were calculated and were repre-
sented as percentage of survival relative to controls.
Statistical analysis
Each experiment was performed three times as individ-
ual experiments with three replicates. Parameters are
expressed as the mean values (+/−SD). Results were ana-
lyzed by unpaired Student’s t-test and by one-way
ANOVA followed by a post-hoc test to compare the pa-
rameters of each group. Differences were considered to
be statistically significant for p < 0.05.Results
The goal of this study was to examine whether alginate
culture is suitable as a 3D tumor microenvironment to
evaluate the malignant potential of CRC cells in an
animal-free in vitro model and to investigate whether
curcumin modulates and improves the effects of 5-FU
on the growth of CRC cells. We evaluated the effects of
curcumin on NF-κB activation, NF-κB-regulated gene
products, cell growth, and invasiveness in CRC cells.
Proliferation and invasion of CRC cells in alginate based
3D culture model mimicking the metastatic tumor
microenvironment in vivo
Morphological investigations of encapsulated HCT116
and HCT116R cells cultured in alginate beads exhibited
typical spherical shape. In all experiments, alginate beads
maintained their globular morphology, did not deform
and no broken beads were observed after 35 days of cul-
ture (not shown). Indeed, incubation of HCT116 and
HCT116R cells either in growth medium (10% FBS) or
in serum-starved medium (3% FBS) resulted in the for-
mation of colonosphere.
I: Phase-contrast microscopic evaluation of HCT116
and HCT116R cells in alginate beads: HCT116 (A-D)
and HCT116R (E-H) cells (1 × 106/ml) were cultured in
alginate beads for periods of up to 3 weeks. On day 1 of
culture, the morphological appearance of the HCT116
and HCT116R cells was rounded and mainly single cells
were embedded in the alginate beads (Figure 1:A, E). On
day 3 of culture, HCT116 and HCT116R cells were dis-
tributed in the alginate beads and several small spheroid
formations were observed (not shown). During the
following days, the tumor cell aggregates grew and
enlarged within the alginate beads. On day 7–10,
small channels developed from tumor cell aggregates
that extended into the alginate beads. The channels
were filled with single or aggregates of cells. In all
beads the channels developed in the same “direction”,
near the surface of beads, and placed to the channel’s
exterior when the alginate bead surface was ruptured,
however the HCT116R cells were more proliferative
and migrated earlier from alginate beads. (Figure 1:B, F).
The migrated cells adopted a spheroid form at the
opening of the channel to the outside of the beads.
The number of detached and migrated cell aggre-
gates of HCT116 cells was significantly increased in
the periphery of the alginate beads during the fol-
lowing days of culture was visible by light microscopy
(Figure 1:C-D, G-H).
II: HCT116 and HCT116R cells exhibit high prolifer-
ation in alginate culture: HCT116 and HCT116R cells
(1 × 106/ml) were cultured in alginate beads for the in-
dicated times, released from alginate and MTT assay
was performed in a 96-well plate. Cells survived the
Figure 1 Light microscopic demonstration of HCT116 (A-D) and HCT116R (E-H) cells (1 × 106/ml) grown in alginate beads culture. Day
1–3 of cultures (A;E), encapsulated cells revealed cell aggregates, the typical spherical shape of HCT116 and HCT116R (arrows). During the
following 7–10 days (B;F), HCT116 and HCT116R cells formed large spheroids and were placed to the channel exterior (arrowheads) when the
alginate bead surface was ruptured. With time, days 14–21 days, HCT116 (C-D) and HCT116R (G-H) cells aggregates enlarged and more and
more cells migrated from the beads. x24, bar=0.2 mm in all cases.
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liferated extensively, as demonstrated by MTT results
(Figure 2). The cells proliferated rapidly, continuously
and doubled their number in 3 days. However,
HCT116R proliferated and grew significantly faster
than HCT116 cells (Figure 2). Moreover, the prolifera-
tion of HCT116 cells reached its maximum after 10
days and HCT116R cells after 14 days in alginate
beads. Taken together, these findings suggest that al-
ginate microenvironments might be an ideal environ-
ment to study proliferation, viability and malignity of
CRC cells in vitro.
III: Evaluation of cell viability by transmission electron
microscopy: To better understand the initial steps of
spontaneous metastasis behavior (proliferation, de-
tachment, invasion) and the viability of HCT116 and
HCT116R cells in alginate beads on the ultrastructure
level, we performed transmission electron microscopy
analysis. After one day culture period, alginate cultures
of HCT116R (not shown) and HCT116 cells showed
single cells and small cell aggregates embedded in algin-
ate structure (Figure 3A). After 3–7 days (Figure 3B-C),Figure 2 Cell viability of HCT116 and HCT116R cells after 21 days
in alginate culture. Proliferation and viability of encapsulated HCT116
and HCT116R cells over 21 days were analyzed by MTT assay.HCT116 cells proliferated and aggregated well in algin-
ate beads. Cells were mainly round to oval, contained a
well-developed rough endoplasmic reticulum, a large
golgi apparatus and other organelles or structures, such
as mitochondria, small vacuoles and granules. After a
culture period of 7 to 14 days (Figure 3C-E), cells
started to rupture alginate structure, formed small
channels with cell aggregates and migrated from the al-
ginate (Figure 3D). The morphology of the HCT116
cells was almost unchanged in the fourth and fifth week
(data not shown). During the cultivation of HCT116
cells in alginate cultures, necrosis/apoptosis occurred in
a small proportion of the cells (Figure 3C-D). HCT116
and HCT116R cells revealed similar distribution profile
and formation of colonospheres on the ultrastructural
level.
Malignancy and metastasis behavior of HCT116 and
HCT116R in alginate cultures
Because colony formation of tumor cells is their
physiologic property in vivo, we evaluated the long-
term invasion and colony formation potential of
CRC cells in vitro. To examine the role and effect of
alginate 3D culture microenvironment on the ability
of CRC cell migration and invasion, HCT116 and
HCT116R cells showed fast and aggressive growth
behavior regarding development of spheroids, spher-
oid size and spheroid distribution and grew continu-
ously for up to 6 weeks (first stage), however the
HCT116R were significantly faster (Figure 4). After
an incubation time of 4–7 days, HCT116 and
HCT116R cells began to invade from alginate cul-
tures (second stage), which continued to increase in
the following days and these cells adhered at the
bottom of the culture flask and proliferated rapidly,
Figure 3 Electron microscopic demonstration of alginate beads with HCT116 spheroids. The HCT116 cells are embedded (A) and divided
(B-C) in alginate beads (*) after 3-7days. They move apart forming more and more aggregates (arrow) and a capsule. The round to oval HCT116
cells cultured in alginate for 10-14 days (D-E), showing cell aggregates within a channel (arrows), proliferating cells emigrating from the beads.
Numerous cells were apoptotic and fragmented (arrowheads). x4.500.
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3 days later (Figure 4). As shown in Figure 4A-B,
the migration and invasion capacity of HCT116R
cells was more and reached a maximum after 22
days in alginate beads.Figure 4 The emigration behavior of HCT116 and HCT116R cells in al
evaluation of the spheroid number (B) emigrated through alginate beads dExpression of tumor metastasis promoting factors in the
3 stages of HCT116 and HCT116R isolated cells in and
from alginate cultures
To further characterize the malignancy and metastatic
ability of HCT116 and HCT116R cells, the proliferationginate 3D culture. Toluidine blue staining (A) and quantitative
uring the culture period from day 1–36.
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profiles in 3D spheroids within alginate beads, in mi-
grated (invaded) and in adherent cells was investigated.
We examined tumor metastasis promoting factors (such
as MMP-9, CXCR4, NF-κB) and performed western
blotting analysis after 1, 7, 14, 21 and 28 days. The
expression of tumor metastasis promoting factors
(Figure 5) was significantly higher in HCT116 and
HCT116R cells isolated from alginate beads or medium
(invaded cells) compared to on the petri dishes bottom
adhered cells during the whole culture period. However,
it was noted that the expression of the above mentioned
proteins was significantly more in 5-FU resistant cells
compared with the parental HCT-116 cells (Figure 5).
Densitometric evaluation of protein expression as re-
vealed by western blot analysis was performed in
triplicate.
Curcumin potentiates the anti-tumor activity of 5-FU by
apoptosis, inhibition of proliferation and colony formation
of HCT116 and HCT116R cells in 3D alginate beads
To examine, whether curcumin can enhance the anti-
proliferation, colony formation and invasion effects of
5-FU in 3D alginate beads, HCT116 and HCT116R cells
were investigated by evaluation of spheroid formation in
alginate beads after 14 days. Curcumin inhibited
proliferation, viability and colony formation of HCT116
and HCT116R cells in a dose-dependent manner in
alginate beads. Curcumin showed similar cytotoxic pro-
file with a maximum effect at 10 μM in HCT116 cells
(Figure 6a: A) compared with 5 μM in HCT116R cells
(Figure 6b: A). It was noted that 5-FU resistant cells
were more sensitive to curcumin compared to theFigure 5 Expression of CXCR4, MMP9 and NF-κB p65, in HCT116 (a) a
compared with migrated (invaded) (I) and adhered (Ad) cells after 1, 7, 14,
and was confirmed by quantitative densitometry. Western blots shown are
protein β-actin served as a positive loading control in all experiments. Valu
with p < 0.05 were designated by an asterisk (*) and p < 0.01 were designaparental HCT116 cells. 5-FU also inhibited proliferation,
viability and colony formation of HCT116 cells in algin-
ate beads and these effects were significant at a concen-
tration of 1nM (Figure 6a:B). Interestingly, it was noted
that there was little or no effect of 5-FU on HCT116R
cells, even after treatment with 10nM dose (Figure 6b:
B), suggesting that HCT116R cells are resistant to 5-FU,
but sensitive to other chemotherapeutic agents, such as
curcumin. To overcome such resistance and to increase
the efficacy of 5-FU, a combined treatment was employed
comprising curcumin and 5-FU. As shown in (Figure 6a:
C; 6b: C) the combination dose of 5 μM curcumin and
0.1nM 5-FU had maximum effect on inhibition of prolif-
eration and viability of HCT116 cells and HCT116R cells
in alginate beads. Colony formation was completely sup-
pressed at these combinations treatment. Interestingly, a
lower concentration of 5-FU was needed in combination
with curcumin to inhibit the proliferation and viability of
HCT116R cells. Thus, it appeared that HCT116R cells
were more susceptible than HCT116 cells to the 5-FU
and curcumin combination. We next examined by trans-
mission electron microscopy whether curcumin can po-
tentiate the cytotoxic effects of 5-FU in HCT116 and
HCT116R cells in alginate beads. Ultrastructural analysis
of treated cells after 14 days showed that curcumin or
5-FU induced similar cytotoxic profile and apoptosis of
HCT116 and HCT116R (not shown) cells in a dose-
dependent manner. Exposure of HCT116 cells to 10 μM
curcumin or 0.1nM 5-FU alone induced minimum effect
on apoptosis in HCT116 cells. As shown in Figure 7A, the
dose of curcumin (5 μM) or 5-FU (0.01nM) that had no
effect on apoptosis alone produced synergistic apoptosis
when combined significantly increased the number ofnd HCT116R (b) cells. Cells encapsulated in alginate beads (A)
21 and 28 days of culture as shown by western blotting evaluation
representative of three independent experiments. The housekeeping
es were compared with the control and statistically significant values
ted by two asterisks (**).
Figure 6 Curcumin increases 5-FU to block the proliferation and viability of HCT116 (a) and HCT116R (b) cells (1 × 106/ml) cultured in
alginate beads. Phase-contrast microscopic observations after 14 days of HCT116 cells (a: A, B, C) (arrows), and HCT116R cells (b: A, B, C)
(arrows) in alginate showed the inhibition of formation of spheroids and viability of cells by curcumin, 5-FU alone and in combination of them in
serum-starved medium. Samples from 3 experiments were analyzed and representative data are shown. x24, bar=0.2 mm in all cases.
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HCT116 cells (Figure 7B) and from 17 to 73% in
HCT116R cells (Figure 7C). Thus, it appeared that
HCT116R cells were more susceptible than HCT116 cells
to the 5-FU and curcumin combination.
Cytotoxic effect of curcumin or/and 5-FU on HCT116 and
HCT116R cells in 3D alginate beads
Because colony formation of tumor cells is an important
behavior to tumor cells physiology and growth in vivo,
and to confirm the anti-proliferative effect of curcu-
min, we evaluated the effect of curcumin on the cyto-
toxic effects of 5-FU on long-term colony formation
and proliferation of HCT116 and HCT116R cells. To
identify the 50% cell proliferation inhibitory concentra-
tions (IC50) and to understand the cytotoxic effect of
curcumin or/and 5-FU on HCT116 and HCT116R cells
in alginate culture, the well-established cell viability
assay (MTT assay) was performed. Curcumin or 5-FU
blocked the proliferation and increased cell death of
HCT116 cells in a dose-dependent manner for each
drug. The HCT116 cells were sensitive to curcumin or
5-FU with an IC50 of 9 μM or 6nM, respectively
(Figure 8A, B). The HCT116R cells were sensitive to
curcumin with an IC50 of 5 μM (Figure 8A). Moreover,
to overcome 5-FU resistance and to increase the
efficacy of curcumin, a combined treatment was per-
formed. The curcumin concentrations were kept con-
stant at 5 μM and different concentrations of 5-FU (0,
0.01, 0.1, 1 and 10nM) were used and the HCT116 and
HCT116R cells were treated for 14 days. Resultsshowed that curcumin significantly enhanced the anti-
proliferative effects of 5-FU and reduced significantly
IC50 values for 5-FU to 0.8nM in HCT116 cells and to
0.1nM in HCT116R cells, respectively (Figure 8C).
These results indicate that curcumin can potentiate
the anti-proliferative and colony-forming effect of
5-FU against HCT116 and HCT116R cells in 3D algin-
ate cultures and HCT116R cells were more susceptible
than HCT116 cells to the 5-FU and curcumin
combination.
Curcumin increased the 5-FU-induced inhibition of
migration (invasion) in HCT116 and HCT116R cells in
alginate-based 3D culture
Tumor cell migration in vivo occurs through the extra-
cellular matrix proteins in tissues. Next, we examined
whether curcumin modulates the anti-tumor effect of
5-FU against CRC migration through 3D alginate-based
culture microenvironment, as an important parameter
to measure cell motility for invasive and metastatic can-
cer cells and evaluated this by toluidine blue staining.
As shown in Figure 9, treatment of the cells with curcu-
min alone inhibited migration of HCT116 and
HCT116R cells through the alginate-based matrix in a
dose-dependent manner with an IC50 of 6 μM and
4 μM, respectively (Figure 9A). Treatment of the cells
with 5-FU alone inhibited migration of HCT116 cells
through the alginate-based matrix in a dose-dependent
manner with an IC50 of 0.4nM (p < 0.05) (Figure 9B).
Interestingly, it was noted that there was little or no
effect of 5-FU on HCT116R cells, even after treatment
Figure 7 Electron microscopic evaluation of mitochondrial and apoptotic changes after treatment with curcumin or/and 5-FU in
HCT116 and HCT116R cells in alginate beads. A: Alginate (*) cultures of HCT116 cells were either left untreated (Co.) or were treated with
different concentrations of curcumin (5, 10 and 20 μM) or 5-FU (0, 0.01, 0.1 and 1nM) or a combination of curcumin (5 μM) and 5-FU (0.01, 0.1 and
1nM) in serum-starved medium for 14 days. Magnification: x5000, bar = 1 μM. B-C: Mitochondrial changes (MC) and apoptosis were quantified by
counting 100 in HCT116 (B) and HCT116R cells (C) with morphological features of apoptotic cell death from 25 different microscopic fields and results
presented are mean values with standard deviations from three independent experiments. Significant values were compared with the control and
statistically significant values with p < 0.05 were designated by an asterisk (*) and p < 0.01 were designated by two asterisks (**).
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to 5-FU, but sensitive to other chemotherapeutic agents,
such as curcumin. Moreover, to evaluate the effect of a
combined treatment of curcumin and 5-FU, HCT116
and HCT-116R cells were co-treated with fixed 5 μM
curcumin and with different concentrations of 5-FU (0,
0.01, 0.1 and 1nM) for 14 days. Interestingly, treatment
with 5 μM curcumin significantly reduced IC50 values
for 5-FU in HCT116 and HCT116R cells with an IC50 of
0.2nM or 0.01nM, respectively (p < 0.05) (Figure 9C).
These results suggest that HCT116 and HCT116R cellstreated with curcumin were more sensitive to 5-FU than
cells treated with 5-FU alone.
Curcumin potentiates 5-FU-induced inhibition of NF-κB
(p65) activation and NF-κB-regulated gene products in
HCT116 and HCT116R cells in 3D alginate beads
To elucidate the underlying mechanism of the sensitivity
HCT116R cells to the curcumin and 5-FU combination,
new experiments were performed. We examined whether
the effects of curcumin on CRC growth and metastasis in
3D alginate cultures was associated with the inhibition of
Figure 8 Curcumin enhances 5-FU to inhibit cell viability of
HCT116 and HCT116R cells. HCT116 and HCT116R cells (1×106/ml)
were treated with different concentrations of curcumin (0, 0.1, 1, 5,
10, 20 μM) (A), 5-FU (0, 0.01, 0.1, 1, 10 nM) (B) or HCT116 and
HCT116R cells were co-treated with curcumin (5 μM) and with 5-FU
in different concentrations (0, 0.01, 0.1, 1, 10 nM) (C) in serum-
starved medium for 14 days and cell viability was measured using the
MTT assay, as described under Material and Methods. Concentrations
of curcumin or/and 5-FU resulting in 50% growth inhibition were
indicated as individual IC50 values. The results are provided as mean
values with standard deviations from at least three independent
experiments. OD value at 100% viable cells was for HCT116 (4.4) and
for HCT116R (6.7). Values were compared with the control and
statistically significant values with p < 0.05 were designated by an
asterisk (*) and p < 0.01 were designated by two asterisks (**).
Figure 9 Curcumin potentiates 5-FU to inhibit migration of
HCT116 and HCT116R cells in alginate beads. Quantification of the
spheroid numbers emigrated through alginate beads after 14 days in
culture. The cultures of HCT116 and HCT116R cells were treated as
described above (A-C) and evaluated by Toluidine blue staining.
Concentrations of curcumin or/and 5-FU resulting in 50% invasion
inhibition were indicated as individual IC50 values. The results are
provided as mean values with standard deviations from at least three
independent experiments. Values were compared with the control and
statistically significant values with p < 0.05 were designated by an asterisk
(*) and p < 0.01 were designated by two asterisks (**).
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NF-κB regulates the expression of genes involved in prolif-
eration, invasion and metastasis [13]. The alginate cultures
were either left untreated or treated with curcumin (0.1, 1,
5, 10 and 20 μM), 5-FU (0.01, 0.1, 1 and 10nM) alone or
were co-treated with fixed concentration of curcumin
(5 μM) and with 5-FU (0.01, 0.1nM) for 14 days. As
shown in Figure 10A, western blot analysis for p65 re-
vealed that curcumin alone significantly inhibited NF-κB
(p65) activation in a dose-dependent manner in HCT116
cells. The dosage of 10-20 μM curcumin almost com-
pletely suppressed the expression of NF-κB (p65)
(Figure 10A,III). The combination of curcumin and 5-FUwas found to be more effective than either agent alone
in down-regulation of NF-κB. Therefore, we examined
further the expression of the gene products which are
involved in proliferation, invasion (MMP-9) and
metastasis (CXCR4) (Figure 10A,I,II). Our western blot
analysis results showed clearly that curcumin alone
down regulated the expression of the mentioned proteins
in a dose-dependent manner, but when the cells were
treated with the combination of curcumin and 5-FU, the
suppression effect of the mentioned proteins significantly
increased (up to 80%) in HCT116 cells. Interestingly, there
was little or no effect of 5-FU on HCT116R cells, even
after treatment with 10nM (Figure 10B: I,II,III), suggesting
Figure 10 Effects of curcumin or/and 5-FU on proliferation-, invasion-, metastatic gene products and NF-κB expression in HCT116 and
HCT116R cells in alginate culture. Curcumin increases 5-FU to inhibit the expression of NF-κB and NF-κB-regulated gene products in HCT116
(A) and HCT116R (B) cells encapsulated in alginate beads. Decreased expression of CXCR4, MMP9 and NF-κB in alginate beads after 14 days of
culture was confirmed by quantitative densitometry. Western blots shown are representative of three independent experiments. The housekeeping
protein β-actin served as a positive loading control in all experiments. Values were compared with the control and statistically significant values with
p < 0.05 were designated by an asterisk (*).
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such resistance and to increase the efficacy of 5-FU, a
combined treatment was employed comprising curcumin
and 5-FU. Interestingly, co-treatment with fixed concen-
tration of curcumin (5 μM) significantly reduced concen-
tration of 5-FU and increased the sensitivity of 5-FU
resistant cell lines. Moreover, it appeared that HCT116R
resistant cells were more susceptible than HCT116 cells
to the 5-FU and curcumin combination. Densitometric
evaluation of protein expression as revealed by western
blot analysis was performed in triplicate (Figure 10). Thus,
the data suggests that the curcumin and 5-FU combin-
ation represents a potential treatment option for 5-FU
resistant CRC.
Discussion
Our results indicated that the in vitro alginate-based 3D
culture model increased proliferation, vitality and meta-
static ability of HCT116 and HCT116R cells, mimicking,
at least partially, the microenvironment of CRC tumor
in vivo. Moreover, in such a culture model, we created
controllable microenvironment conditions, whereby we
could understand some of the key biological behaviors of
HCT116 and HCT116R cells exhibited in vivo in the
tumor environment and investigated the anti-cancer,
-metastasis activity of chemopreventive agent (curcumin)
and its potentiation effect on commonly used chemother-
apy agent (5-FU) against the HCT116 and HCT116R
tumor cells.
The results of this study lead to the following novel
findings: (1) HCT116 and HCT116R cells cultured in
alginate beads were able to proliferate in colonospheres,
were viable and malignant for over 21 days in a vivo-like
phenotype. (2) During cultivation of HCT116 andHCT116R cells in the same alginate cultures, 3 stages of
cells were isolated, (a) in alginate proliferating-, (b) in
medium invasive- and (c) on the petri dish adhered cells.
(3) The expression of tumor-promoting factors (CXCR4,
MMP-9, NF-κB), which are involved with CRC prolifera-
tion, metastasis and tumor invasion were significantly
increased in the alginate proliferating- and invasive cells
compared to the adhered cells, however HCT116R over-
expressed more proteins in comparison to the HCT116
cells. (4) Curcumin chemosensitized CRC cells and
potentiated 5-FU-induced inhibition of survival, prolifer-
ation, invasion and metastatic ability of cells in a dose-
dependent manner and increased more sensitivity to 5-FU
of HCT116R compared to the HCT116 cells in alginate
cultures. (5) The individual IC50 cell death of curcumin or
5-FU was approximately 9 μM or 6nM in HCT116 cells,
but co-treatment with fixed concentration of curcumin
(5 μM) significantly reduced concentration of 5-FU in
HCT116 and HCT116R cells (0.8nM and 0.1nM, respect-
ively) to achieve the same effect in the cells. (6) Finally,
these effects were accompanied by down-regulation of
NF-κB activation and NF-κB-regulated gene products.
In this study, we showed that the 3D alginate bead
scaffold can serve as a matrix that realizes adequate con-
ditions to induce cultured tumor cells towards a more
malignant in vivo-like phenotype. Furthermore, we have
developed a 5-FU resistant cell line from HCT116 cells
by continuous treatment with 5-FU. These cells were
resistant to 5-FU. We found that both CRC cell lines
proliferated to tumor spheroids, natural behavior of
many tumor cells, aggregated and migrated from the
3D-based alginate beads matrix. Moreover, the expres-
sion of proliferation- and metastasis-related proteins in
HCT116 and HCT116R cells were significantly increased
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to the adhered cells on the bottom of petri dishes.
However, HCT116R cells overexpressed more proteins
and factors in comparison to the HCT116 cells, indicat-
ing for an increase in cancer malignancy. Thus, these re-
sults indicate the suitability of the 3D alginate bead
culture as an ideal specific microenvironmental condi-
tion for CRC cells as it is significantly more representa-
tive of the tumor microenvironment than the monolayer
cell culture. Furthermore, this spherical alginate-beads
culture can be easily dissolved and the survived cells
may be further investigated for proliferation, viability
and metastatic ability of CRC cells and support the
tumor microenvironment similar of that in vivo. In vitro
cell-based experiments are expected to advance the re-
sults during early stages of the detection of remedy
process by providing a cell specific response. To create
such as microenvironment with stable cell differentiation
in cultured cells, it is essential for obtaining and under-
standing the role of reliable biomedical data on cell
phenotype and function [43]. Several reports have sug-
gested that a 3D surrounding affects cell morphology, up-
regulates the stem cell surface marker expression and
thereby specific gene and protein expression patterns of
potentially functional relevance in different tumor mam-
mary cell lines compared with their 2D counterparts
[8,44-47] and maintain their specific cell viability for a
long time [48]. However, the cells in the monolayer cul-
tures lose their differentiation and cell-specific physio-
logical functions rapidly, seriously impairing the
prognostic ability of such assays. This is to gain by cultur-
ing the cells within specific 3D scaffolds in vitro such as
collagen types I and II, high density- or alginate cultures
[4,30,43,45,49].
5-FU is widely used for the treatment of many types of
cancers and is routinely employed in the management of
colorectal cancer [50]. However, a serious problem with
5-FU treatment is that more than 50% of patients show
resistance to 5-FU in the clinical setting, suggesting that
no effective therapies with chemotherapeutic drugs are
available and there is a great need for improved
therapies and novel treatment approaches. Therefore,
biological agents that can sensitize tumor cells to
chemotherapeutic agents have great potential in treat-
ment of cancer. Notably, several studies have shown that
curcumin (diferuloylmethane), sensitizes CRC cells to
5-FU, oxaliplatin, celecoxib and to provide additional clin-
ical benefit for patients with metastatic colorectal cancer
[26,30-33,42,51-54]. We have further shown how curcu-
min potentiates the effects of a traditional chemotherapy
agent (5-FU), by mediating its effects as anti-metastasis
and -proliferative drug on HCT116 and HCT116R cell
viability, proliferation and metastasis in alginate-based 3D
culture model. Furthermore, curcumin alone and with5-FU markedly reduced the capacity for colonosphere
formation, migration and invasiveness of the HCT116
and HCT116R cells. We found in our in vitro cytotoxicity
study that the individual IC50 of curcumin or 5-FU to
HCT116 cells was 9 μM or 6nM, respectively (p < 0.05)
and of curcumin to HCT116R cells was 5 μM. Moreover,
co-treatment with fixed concentration of curcumin
(5 μM) decreased significantly concentration of 5-FU
in HCT116 and HCT116R cell (0.8nM and 0.1nM,
respectively) to achieve the same effect in cells.
Thus, the results suggest that 5-FU resistant cells are sen-
sitive to chemotherapeutic agents, such as curcumin and
the curcumin and 5-FU combination represents a poten-
tial treatment option for 5-FU resistant colon cancer.
To study the mechanism of action of the 5-FU and
curcumin combination, we have first analyzed whether
NF-κB transcription factor pathway was involved. In-
deed, multiple pieces of evidence have shown that the
NF-κB transcription factor is constitutively present and
active in human colorectal tumor and that NF-κB activa-
tion was associated with a resistance to chemotherapy
treatment [55-57]. Therefore, inhibition of NF-κB may
be a key therapeutic target to render colorectal tumor
cells susceptible to chemotherapeutic agents. Indeed,
we examined the molecular mechanisms that support
curcumin-mediated inhibition of CRC growth. Curcumin
markedly down-regulated the activation and phosphoryl-
ation of NF-κB and NF-κB-regulated gene products that
are involved in growth, proliferation, invasion (MMP-9)
and metastasis (CXCR4) in CRC cells. Indeed, it has been
reported that expression of CXCR4 is associated with an
enhanced risk of CRC cells recurrence and survival [58].
These results are in agreement with those which showed
that curcumin down-regulates NF-κB pathway through
inhibition of IκBα kinase activation and IκBα phosphor-
ylation in CRC cells [26]. Furthermore, our electron mi-
croscopy analysis demonstrated clearly that curcumin
alone or/and in combination with 5-FU enhanced apop-
tosis in HCT116 and HCT116R tumor cells in alginate
cultures. Curcumin has potentiated the anti-cancer ac-
tivity of 5-FU in a synergistic inhibition of viability and
proliferation against CRC cells in alginate beads in vitro.
This is in agreement with previous investigations from
our laboratory and from others which have shown that cur-
cumin blocks the activation of NF-κB and exhibits synergis-
tic activity with 5-FU against tumor cells [26,30,59-61].
Moreover, our results showed that curcumin potentiated
the antitumor effects of 5-FU against 2 CRC cell lines
in vitro. This finding is further in agreement with other
studies showing that curcumin exhibits synergistic activity
with 5-FU against HT 29 cells [60]. Du and co-workers
have shown that curcumin suppresses COX-2 levels in
HT 29 cells; this may account for its synergistic effects.
Our results, however, indicate that curcumin blocks the
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are regulated by NF-κB and are involved in proliferation,
invasion and metastasis. Thus, we suggest that this finding
might have a potential implication for the prevention and
treatment of colorectal tumor. Because curcumin is a
component of a wide variety of fruits actively consumed
by most humans and is well tolerated [22], it is preferable
to examine the mechanism of action of curcumin.
It has been reported that for cancer cells in order to
form metastases, the cells proliferate locally, detach from
the primary environment and migrate through the tissue
and survive in the circulation, adhere and proliferate at a
distant organ [62]. However, it is not possible to
demonstrate the important initial steps of spontaneous
carcinogenesis and metastasis (local tumor growth,
detachment and invasion) under in vivo condition. But,
in our alginate model, CRC cells encapsulated in
alginate beads proliferated with detachment of the cells
from the alginate environment and formed CRC me-
tastases, suggesting that this 3D model is essential and
quite comfortable to recapitulate in vitro the sequential
steps of CRC metastasis (malignancy) in vivo. Addition-
ally, we have shown that curcumin increased the 5-FU-
induced inhibition of HCT116R cells invasion compared
with HCT116. Fifty percent of HCT116 cell invasion was
blocked when 0.1nM 5-FU was added with fixed concen-
tration of curcumin (5 μM), but a much lower concentra-
tion of 5-FU (0.01nM) was needed to achieve the same
effect in 5-FU resistant cells, indicating that curcumin
was more effective to sensitize the HCT116R cells than
HCT-116 cells when combined with 5-FU.
Conclusions
In conclusion, for the first time, we describe herein the
monitoring of an alginate-based spherical beads culture
model to provide a 3D biocompatible microenvironment
for CRC cells in vitro for long-term cultivation. Moreover,
this can improve the quality of in vitro drug screening,
pre-testing animal-free clinical treatment, investigation of
the initial steps of spontaneous carcinogenesis and metas-
tasis. Additionally, our results suggest that curcumin
sensitizes CRC cells to 5-FU, at least in part by suppress-
ing of NF-κB signaling pathway, indicating combination of
curcumin and 5-FU may be useful to overcome 5-FU
resistance in CRC patients.
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